SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-000014
Filing Date
2022-01-03
Accepted
2022-01-03 09:00:15
Documents
2
Period of Report
2021-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K thct_8k.htm 8-K 18525
2 CONSULTING AGREEMENT thct_101.htm EX-10.1 52291
  Complete submission text file 0001477932-22-000014.txt   72253
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

IRS No.: 260164981 | Fiscal Year End: 0729
Type: 8-K | Act: 34 | File No.: 000-55994 | Film No.: 22500545
SIC: 3523 Farm Machinery & Equipment